These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 12467136

  • 1. Timing of supplementation with the antioxidant N-acetyl-L-cysteine reduces tumor multiplicity in novel, cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) transgenic mice but has no impact on malignant progression.
    Martin KR, Saulnier MJ, Kari FW, Barrett JC, French JE.
    Nutr Cancer; 2002; 43(1):59-66. PubMed ID: 12467136
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. N-acetyl-L-cysteine simultaneously increases mitogenesis and suppresses apoptosis in mitogen-stimulated B-lymphocytes from p53 haploinsufficient Tg.AC (v-Ha-ras) mice.
    Martin KR, Kari FW, Barrett JC, French JE.
    In Vitr Mol Toxicol; 2000; 13(4):237-48. PubMed ID: 11319275
    [Abstract] [Full Text] [Related]

  • 5. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM, Spalding JW, Tennant RW, Smart RC.
    Cancer Res; 1995 Jul 15; 55(14):3171-8. PubMed ID: 7606738
    [Abstract] [Full Text] [Related]

  • 6. Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53.
    Zhang Z, Yao R, Li J, Wang Y, Boone CW, Lubet RA, You M.
    Mol Cancer Res; 2005 Oct 15; 3(10):563-74. PubMed ID: 16254190
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X, Lee J, Cooley M, Bhogte E, Hartley S, Glick A.
    Cancer Res; 2003 Nov 15; 63(22):7760-8. PubMed ID: 14633701
    [Abstract] [Full Text] [Related]

  • 11. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice.
    Tober KL, Cannon RE, Spalding JW, Oberyszyn TM, Parrett ML, Rackoff AI, Oberyszyn AS, Tennant RW, Robertson FM.
    Biochem Biophys Res Commun; 1998 Jun 29; 247(3):644-53. PubMed ID: 9647747
    [Abstract] [Full Text] [Related]

  • 12. beta-Carotene fails to act as a tumor promoter, induces RAR expression, and prevents carcinoma formation in a two-stage model of skin carcinogenesis in male Sencar mice.
    Ponnamperuma RM, Shimizu Y, Kirchhof SM, De Luca LM.
    Nutr Cancer; 2000 Jun 29; 37(1):82-8. PubMed ID: 10965524
    [Abstract] [Full Text] [Related]

  • 13. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL.
    Cancer Res; 1996 Dec 01; 56(23):5391-6. PubMed ID: 8968091
    [Abstract] [Full Text] [Related]

  • 14. A transgenic mouse model (TG.AC) for skin carcinogenesis: inducible transgene expression as a second critical event.
    Hansen LA, Spalding JW, French JE, Tennant RW.
    Prog Clin Biol Res; 1995 Dec 01; 391():223-35. PubMed ID: 8532720
    [Abstract] [Full Text] [Related]

  • 15. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1995 May 01; 429():1-286. PubMed ID: 12616302
    [Abstract] [Full Text] [Related]

  • 16. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
    Leder A, McMenamin J, Zhou F, Moran JL, Beier DR, Leder P.
    Oncogene; 2008 Apr 10; 27(17):2456-65. PubMed ID: 17952114
    [Abstract] [Full Text] [Related]

  • 17. The effect of dietary supplementation of N-acetyl-L-cysteine on glutathione concentration and lipid peroxidation in cigarette smoke-exposed rats fed a low-protein diet.
    Alhamdan AA.
    Saudi Med J; 2005 Feb 10; 26(2):208-14. PubMed ID: 15770292
    [Abstract] [Full Text] [Related]

  • 18. Tumor-preventive effects of the soluble p53 antigen on chemically-induced skin cancer in mice.
    Ben-Hur H, Ben-Meir A, Hagay Z, Ben-Meir A, Berman V, Schwartsburd B, Gurevich P, Sandler B, Tendler Y, Zinder O, Zusman I.
    Anticancer Res; 1998 Feb 10; 18(6A):4237-41. PubMed ID: 9891473
    [Abstract] [Full Text] [Related]

  • 19. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mice expressing epidermal-targeted v-fos induces rasHA-activated papillomas and carcinomas without p53 mutation: association of v-fos expression with promotion and tumor autonomy.
    Greenhalgh DA, Wang XJ, Eckhardt JN, Roop DR.
    Cell Growth Differ; 1995 May 10; 6(5):579-86. PubMed ID: 7544154
    [Abstract] [Full Text] [Related]

  • 20. Protection against malignant conversion of chemically induced benign skin papillomas to squamous cell carcinomas in SENCAR mice by a polyphenolic fraction isolated from green tea.
    Katiyar SK, Agarwal R, Mukhtar H.
    Cancer Res; 1993 Nov 15; 53(22):5409-12. PubMed ID: 8221679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.